Very early pulmonary function decline in systemic sclerosis: longitudinal evidence from the STRIKE and EUSTAR VEDOSS cohorts
Mean forced vital capacity (FVC) at interstitial lung disease (ILD) diagnosis in EUSTAR is approximately 87%, suggesting a period of pulmonary function decline prior to ILD detection. Here we analysed longitudinal pulmonary function trajectories in patients with very early diagnosis of systemic sclerosis (VEDOSS) to identify lung function decline at this very early stage of disease. We performed a retrospective analysis of two independent VEDOSS cohorts from the STRIKE and EUSTAR databases. Patients were included at baseline if they fulfilled VEDOSS criteria but did not meet the 2013 ACR/EULAR systemic sclerosis classification criteria and had at least one follow-up pulmonary function test (PFT). Very Early pulmonary function decline was defined as an absolute ≥ 10% decline in forced vital capacity (FVC), or a 5–9% FVC decline accompanied by a ≥ 15% decline in diffusing capacity of the lung for carbon monoxide (DLCO), at any time during follow-up. Clinical features and available serum biomarkers were compared between progressors and non-progressors. A total of 455 patients (77 STRIKE; 378 EUSTAR) were included. PFT-defined lung function decline was observed in 22.1% of patients in the STRIKE cohort and 17.2% in the EUSTAR cohort. Baseline DLCO was reduced in both cohorts (STRIKE: 90% ±18; EUSTAR: 85% ±16) despite preserved FVC (STRIKE: 102% ±15; EUSTAR: 106% ±16). 46.3% of patients with lung function decline fulfilled the 2013 ACR/EULAR SSc classification criteria during follow-up. Serum markers of extracellular matrix (ECM) turnover comprising the Enhanced Liver Fibrosis (ELF) score, were higher in progressors at baseline and follow-up compared with non-progressors in the STRIKE cohort. Time-to-event analysis demonstrated a cumulative incidence of very early pulmonary function decline of 20.4% (95% CI 15.0–25.4) at 5 years in the combined cohort. A substantial minority of patients with VEDOSS demonstrate measurable pulmonary function decline prior to fulfilment of classification criteria. Elevated markers of ECM turnover support the presence of early fibrotic activity in this subgroup. Our findings warrant the implementation of early ILD detection strategies in patients with very early diagnosis of SSc even if they do not fulfil classification criteria for the disease.
Authors
- S. Blaise (ORCID: https://orcid.org/0000-0001-7238-112X)
- Roberta Foti (ORCID: https://orcid.org/0000-0002-3074-4508)
- Andra Rodica Balanescu (ORCID: https://orcid.org/0000-0003-0688-9173)
- Marco Matucci‐Cerinic (ORCID: https://orcid.org/0000-0002-9324-3161)
- Yannick Allanore (ORCID: https://orcid.org/0000-0002-6149-0002)
- Stefano Di Donato (ORCID: https://orcid.org/0000-0003-1256-0761)
- Silvia Bellando-Randone (ORCID: https://orcid.org/0000-0002-5926-6263)
- Francesco Del Galdo (ORCID: https://orcid.org/0000-0002-8528-2283)
- V. Smith
- Veronica Batani (ORCID: https://orcid.org/0000-0003-4402-4250)
- Radim Bečvář (ORCID: https://orcid.org/0000-0003-0022-3135)
- Lucy Thornton
- Maria De Santis (ORCID: https://orcid.org/0000-0002-3196-1336)
- Emmanuel Chatelus (ORCID: https://orcid.org/0000-0002-7360-6527)
- Jelena Colic (ORCID: https://orcid.org/0000-0002-8418-3056)
- Gabór Kumánovics (ORCID: https://orcid.org/0000-0001-8500-2918)
- Vishal Kakkar (ORCID: https://orcid.org/0000-0003-0513-8677)
- Lesley-Anne Bissell (ORCID: https://orcid.org/0000-0002-2789-4652)
- Ulf Müeller-Ladner
- Florenzo Iannone
- Nicola Ortalli
- Katja Perdan Pirkmajer
Institutions
- University of Modena and Reggio Emilia (IT)
- University of Leeds (GB)
- Humanitas University (IT)
- Vita-Salute San Raffaele University (IT)
- Carol Davila University of Medicine and Pharmacy (RO)
- University of Cagliari (IT)
- Justus-Liebig-Universität Gießen (DE)
- Université Paris Cité (FR)
- Charles University (CZ)
- Chapel Allerton Hospital (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Centre Hospitalier Universitaire de Grenoble (FR)
- Ljubljana University Medical Centre (SI)
- Ghent University (BE)
- National Institute for Health and Care Research (GB)
- Institute of Rheumatology (CZ)
- Hôpital Cochin (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- IRCCS Ospedale San Raffaele (IT)
- Hôpitaux Universitaires de Strasbourg (FR)
- Hôpital d'Hautepierre (FR)
- Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" (IT)
- IRCCS Humanitas Research Hospital (IT)
- University of Florence (IT)
- University of Bari Aldo Moro (IT)
- University of Pecs (HU)
Publication Details
- Journal
- Arthritis Research & Therapy
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1186/s13075-026-03945-0
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00